This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Pretargeting: A Path Forward for Radioimmunotherapy
- Current Landscape in Clinical Pretargeted Radioimmunoimaging and Therapy
- Pretargeted Imaging and Therapy
- Antibody Pretargeting Advances Cancer Radioimmunodetection and Radioimmunotherapy
- Improving the Delivery of Radionuclides for Imaging and Therapy of Cancer Using Pretargeting Methods
- Perspectives on Cancer Therapy with Radiolabeled Monoclonal Antibodies
- In Vivo Evaluation of Pretargeted 64Cu for Tumor Imaging and Therapy
- Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts
- Pretargeting radioimmunotherapy of a murine model of adult T-cell leukemia with the alpha -emitting radionuclide, bismuth 213
- Molecular Advances in Pretargeting Radioimunotherapy with Bispecific Antibodies
- Tumor Pretargeting in Mice Using 99mTc-Labeled Morpholino, a DNA Analog
- Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity
- Tumor Pretargeting with Avidin Improves the Therapeutic Index of Biotinylated Tumor Necrosis Factor {{alpha}} in Mouse Models